Mallinckrodt PLC (NYSE:MNK) – Stock analysts at Oppenheimer Holdings lowered their Q4 2017 EPS estimates for shares of Mallinckrodt PLC in a report issued on Tuesday. Oppenheimer Holdings analyst D. Archila now forecasts that the company will post earnings per share of $2.10 for the quarter, down from their prior estimate of $2.11. Oppenheimer Holdings currently has a “Buy” rating and a $70.00 target price on the stock.
A number of other research analysts also recently weighed in on the stock. Mizuho reaffirmed a “buy” rating and issued a $70.00 target price (down previously from $73.00) on shares of Mallinckrodt PLC in a research report on Wednesday. BMO Capital Markets reaffirmed an “outperform” rating and issued a $65.00 target price (down previously from $69.00) on shares of Mallinckrodt PLC in a research report on Wednesday. Raymond James Financial, Inc. decreased their target price on shares of Mallinckrodt PLC from $65.00 to $58.00 and set an “outperform” rating for the company in a research report on Wednesday. Deutsche Bank AG set a $56.00 target price on shares of Mallinckrodt PLC and gave the company a “buy” rating in a research report on Wednesday. Finally, UBS AG set a $70.00 target price on shares of Mallinckrodt PLC and gave the company a “buy” rating in a research report on Wednesday. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $72.44.
COPYRIGHT VIOLATION WARNING: “Mallinckrodt PLC (NYSE:MNK) to Post Q4 2017 Earnings of $2.10 Per Share, Oppenheimer Holdings Forecasts” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/2802136/mallinckrodt-plc-nysemnk-to-post-q4-2017-earnings-of-2-10-per-share-oppenheimer-holdings-forecasts.html.
Mallinckrodt PLC (NYSE:MNK) traded down 2.43% during midday trading on Friday, hitting $36.14. 980,118 shares of the company traded hands. The stock’s 50-day moving average is $44.13 and its 200-day moving average is $45.63. The firm’s market capitalization is $3.51 billion. Mallinckrodt PLC has a 12-month low of $36.02 and a 12-month high of $85.83.
Mallinckrodt PLC (NYSE:MNK) last released its quarterly earnings data on Tuesday, August 8th. The company reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.12. Mallinckrodt PLC had a net margin of 12.64% and a return on equity of 15.28%. The business had revenue of $824.50 million during the quarter, compared to analyst estimates of $829.56 million. During the same quarter in the previous year, the business earned $2.03 EPS. Mallinckrodt PLC’s quarterly revenue was down 4.9% compared to the same quarter last year.
Several hedge funds have recently bought and sold shares of MNK. BlackRock Inc. boosted its stake in Mallinckrodt PLC by 4,060.7% in the first quarter. BlackRock Inc. now owns 8,734,709 shares of the company’s stock worth $389,307,000 after buying an additional 8,524,773 shares in the last quarter. Wells Fargo & Company MN boosted its stake in Mallinckrodt PLC by 9.7% in the first quarter. Wells Fargo & Company MN now owns 164,309 shares of the company’s stock worth $7,322,000 after buying an additional 14,485 shares in the last quarter. LS Investment Advisors LLC boosted its stake in Mallinckrodt PLC by 18.5% in the first quarter. LS Investment Advisors LLC now owns 6,116 shares of the company’s stock worth $273,000 after buying an additional 955 shares in the last quarter. Acadian Asset Management LLC boosted its stake in Mallinckrodt PLC by 48.9% in the first quarter. Acadian Asset Management LLC now owns 723,612 shares of the company’s stock worth $32,252,000 after buying an additional 237,728 shares in the last quarter. Finally, RBF Capital LLC bought a new stake in Mallinckrodt PLC during the first quarter worth about $891,000. Institutional investors own 95.71% of the company’s stock.
In related news, VP Hugh M. O’neill bought 1,000 shares of the business’s stock in a transaction dated Thursday, June 8th. The stock was bought at an average price of $40.24 per share, for a total transaction of $40,240.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Coleman N. Lannum III bought 1,350 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were bought at an average price of $42.89 per share, with a total value of $57,901.50. Following the purchase, the vice president now owns 30,955 shares in the company, valued at approximately $1,327,659.95. The disclosure for this purchase can be found here. In the last 90 days, insiders have bought 3,850 shares of company stock valued at $157,687. 0.77% of the stock is currently owned by corporate insiders.
About Mallinckrodt PLC
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and hemostasis products, and central nervous system drugs.
Receive News & Ratings for Mallinckrodt PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt PLC and related companies with MarketBeat.com's FREE daily email newsletter.